Edward Berger has over 25 years of experience in senior management and consulting for medical device, biotechnology, and health services companies. He specializes in addressing the obstacles and opportunities faced by these companies in securing public and private insurer coverage and optimal reimbursement for new or evolving technologies. Berger founded Larchmont Strategic Advisors in 2005 to use his expertise in areas such as reimbursement analysis, public policy evaluation, regulatory compliance, strategic planning, crisis management, media relations, and investor relations. He has served clients in various fields, including interventional pulmonology, mechanical circulatory supports, clinical laboratory testing, personalized medicine, stroke rehabilitation, neurostimulation and neuroregeneration, kidney dialysis, and laser technologies in medicine. Berger studied a Bachelor of Arts in Government at Harvard University and a Doctor of Philosophy in Political Science at Boston University. He has also been a former member of the Board of Directors at Metropolitan Waterworks Museum, Mass Medical Angels, and served in senior positions, including CEO and Vice-President, in various companies such as Atanse, Inc., Coraux Technologies, ABIOMED, Inc., Fresenius Medical Care, and GeNO, LLC.